Sun Pharma Advanced Research Company Ltd share price logo

Sun Pharma Advanced Research Company Ltd

NSE: SPARC

BSE: 532872

Small Cap

Pharma Sector

₹212.82

-0.15

(-0.07%)

as on

bell
The current prices are delayed by 15 mins, login to check live prices.

Tech Chart

Sun Pharma Stock Performance

as on June 5, 2026 at 9:31 pm IST

  • Day's Low

    Day's High

    ₹210.90
    ₹222.59
    downward going graph

    0.90%

    Downside

    4.59%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    ₹108.00
    ₹248.75
    downward going graph

    49.25%

    Downside

    16.88%

    Upside

    downward going graph

Sun Pharma share price movements today

Previous Close
₹212.97
Open
₹214.05
Volume
36.08L
Upper Circuit
₹234.26
Lower Circuit
₹191.68
Day's Low - High
₹210.90 - ₹222.59
52 Week Low - High
₹108.00 - ₹248.75

Sun Pharma Historical Returns

1 Month Return
+ 52.12 %
3 Month Return
+ 71.64 %
1 Year Return
+ 31.43 %
3 Year Return
+ 13.19 %
5 Year Return
-8.4 %

Sun Pharma Fundamentals

as on June 5, 2026 at 4:01 pm IST

Market Cap

₹6,911.34 Cr

Return on Equity (ROE)

0

PE Ratio (TTM)

4.45

Return on capital employed (ROCE)

0

Industry PE ratio

44.89

Beta (LTM)

1.69

P/B Ratio

-21.76

Dividend Yield

0

PEG Ratio

0.08

Quarterly Earnings Growth YOY

-3046.86

EPS (TTM)

-10.55

Book Value

-6.68

Sun Pharma Stock Valuation

as on June 5, 2026 at 4:01 pm IST

Sun Pharma in the last 5 years

  • Overview

  • Trends

Lowest (-38.16x)

April 8, 2024

Today (4.45x)

June 4, 2026

Industry (44.89x)

June 4, 2026

Highest (4.92x)

May 26, 2026

LowHigh

Today’s Price to Earnings Ratio: 4.45x

Sun Pharma Technical Analysis

Track how Sun Pharma technical analysis has moved over time to understand its trends.

1 min
5 min
15 min
30 min
1 day
1 week
1 month

Technicals Summary

Bearish

Neutral

Bullish

Bullish

Moving Averages

Bearish

Neutral

Bullish

Bullish

Oscillators

Bearish

Neutral

Bullish

Bullish

Overall

Bearish3
Bullish11
Neutral1

Oscillators

Name

Value

Action

MACD level (12,26)
0.19
Bullish
CCI (20)
292.86
Bearish
RSI (14)
56.52
Neutral
Momentum (10)
0.05
Bullish
ADI (14)
30.58
Bullish
Ultimate Oscillator (7,14,28)
27.91
Bearish

Moving Averages

Name

Value

Action

SMA (20)
212.78
Bullish
EMA (20)
212.93
Bullish
VWMA (20)
213.05
Bullish
SMA (50)
212.73
Bullish
EMA (50)
212.7
Bullish
SMA (200)
213.27
Bearish
EMA (200)
213.09
Bullish
KAMA (200)
212.42
Bullish
DEMA (200)
212.41
Bullish

Sun Pharma Advanced Research Company Ltd vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Sun Pharma with its industry peers.

Company
Analyst View
Market Cap(in ₹ Cr)
5 Year CAGRDebt to Asset Ratio
Net Profit(in ₹ Cr)
Yearly Revenue(in ₹ Cr)
Sun Pharma Advanced Research Company Ltd image
Sun Pharma Advanced Research Company Ltd
BUY6,911.34-1.68%1.88-34371
Cohance Lifesciences Ltd image
Cohance Lifesciences Ltd
HOLD16,270.58-3.51%0.682641,197
Jubilant Pharmova Ltd image
Jubilant Pharmova Ltd
BUY15,463.254.69%0.718367,234
Rainbow Childrens Medicare Ltd image
Rainbow Childrens Medicare Ltd
BUY13,680.0239.84%0.672441,515
Poly Medicure Ltd image
Poly Medicure Ltd
HOLD14,241.017.67%0.533381,669
See all

Market expectation of Sun Pharma Stock

Common consensus of the market based on various publicly available news, publications,brokerage expectation and market data

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Sun Pharma Stock’s Investor Sentiment and Interest

Investment in Sun Pharma Advanced Research Company Ltd Shares on INDmoney has grown by 283.54% over the past 30 days, indicating increased transactional activity.

Time period: to

Change:283.54% versus previous 30 day period

Search interest for Sun Pharma Advanced Research Company Ltd Stock has increased by 66% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:66% versus previous 30 day period

Sun Pharma Advanced Research Company Ltd Quarterly Profit & Loss

Figures in Rupees Crores

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Sales
23.95
21.18
13.86
16.56
16.81
12.86
14.91
27.19
9.64
7.86
8.45
13.2
Other Income
10.19
8.49
6.39
4.4
1.56
0.04
0.19
-
9.14
0.01
-
1.8
Total Income
34.14
29.67
20.25
20.96
18.37
12.9
15.1
27.19
18.78
7.87
8.45
1,855.02
Expenses
126.13
112.65
116.48
122.39
110.17
115.77
88.6
80.37
61.72
73.58
77.45
80.02
Operating Profit
-102.18
-91.47
-102.62
-105.83
-93.36
-102.91
-73.69
-53.18
-52.08
-65.72
-69
-66.82
Operating Profit Margin %
-426.64%
-431.87%
-740.4%
-639.07%
-555.38%
-800.23%
-494.23%
-195.59%
-540.25%
-836.13%
-816.57%
-506.21%
Profit Before Interest, Tax and Depreciation
-91.99
-82.98
-96.23
-101.43
-91.8
-102.87
-73.5
-53.18
-42.94
-65.71
-69
1,775
Interest
0.26
0.26
0.26
0.91
0.56
1.14
2.8
4.54
6.19
7.52
8.78
11.64
Depreciation
3.1
3.18
3.16
3.07
3.14
3.16
3.14
2.95
2.68
2.56
2.57
2.4
Profit Before Tax
-95.35
-86.42
-99.65
-105.41
-95.5
-107.17
-79.44
-60.67
-51.81
-75.79
-80.35
1,760.96
Tax Paid
-
-
-
0.38
0.4
0.16
0.07
-0.9
0.06
0.06
0.07
-0.38
Profit After Tax
-95.35
-86.42
-99.65
-105.79
-95.9
-107.33
-79.51
-59.77
-51.87
-75.85
-80.42
1,761.34
Total Net profit including share of profit / Loss from associate company
-95.35
-86.42
-99.65
-105.79
-95.9
-107.33
-79.51
-59.77
-51.87
-75.85
-80.42
1,761.34
EPS
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
-2.48
54.27
Actual EPS
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
-2.48
54.27
Adjusted EPS
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
-2.48
54.27
Diluted EPS
-2.94
-2.66
-3.07
-3.26
-2.96
-3.31
-2.45
-1.84
-1.6
-2.34
-2.48
54.27

Sun Pharma Advanced Research Company Ltd Annual Profit & Loss

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Mar 2026
Sales
238.78
75.55
71.77
39.15
Other Income
10.88
29.47
1.79
10.95
Total Income
249.66
105.02
73.56
1,890.12
Expenses
452.84
477.65
394.91
292.77
Operating Profit
-214.06
-402.1
-323.14
-253.62
Operating Profit Margin %
-89.65%
-532.23%
-450.24%
-647.82%
Profit Before Interest, Tax and Depreciation
-203.18
-372.63
-321.35
1,597.35
Interest
7.63
1.69
9.04
34.13
Depreciation
11.77
12.51
12.39
10.21
Profit Before Tax
-222.58
-386.83
-342.78
1,553.01
Tax Paid
-
0.38
-0.27
-0.19
Profit After Tax
-222.58
-387.21
-342.51
1,553.2
Total Net profit including share of profit / Loss from associate company
-222.58
-387.21
-342.51
1,553.2
EPS
-7.82
-11.93
-10.55
47.86
Actual EPS
-7.82
-11.93
-10.55
47.86
Adjusted EPS
-7.82
-11.93
-10.55
47.86
Diluted EPS
-7.82
-11.93
-10.55
47.86

Sun Pharma Advanced Research Company Ltd Cash Flow

Figures in Rupees Crores

Mar 2023
Mar 2024
Mar 2025
Net Cash from Operating Activities
-69.12
-429.19
-360.29
Cash Flow from Investing Activities
-548.28
391.53
157.67
Cash Flow from Financing Activities
616.75
42.41
199.25
Net Cash Flow
-0.64
4.75
-3.37

Sun Pharma Stock Shareholding Pattern

Numbers in percentages

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
May 2026
Promoters
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
65.67%
DII
0.23%
0.81%
0.82%
0.18%
0.23%
0.64%
1.13%
0.97%
1.05%
0.78%
0.88%
0.1%
FII
0%
3.3%
3.23%
2.64%
2.15%
2.23%
1.45%
1.47%
1.76%
2.04%
2.04%
2.47%
Public
29.86%
30.21%
30.28%
31.51%
31.95%
31.46%
31.75%
31.88%
31.52%
31.5%
31.41%
31.76%
Total Outstanding Shares
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
32,45,21,588
Total Shareholders
1,01,433
1,03,990
1,02,743
1,25,184
1,28,205
1,31,034
1,42,864
1,40,724
1,36,997
1,44,810
1,40,625
1,37,538

Sun Pharma Corporate Actions

View detailed summary of the earnings and dividend history of Sun Pharma.

  • Sun Pharma Advanced Research Company Ltd Earnings Results

    Sun Pharma Advanced Research Company Ltd’s net profit jumped 3046.86% since last year same period to ₹1,761.34Cr in the Q4 2025-2026. On a quarterly growth basis, Sun Pharma Advanced Research Company Ltd has generated 2290.18% jump in its net profits since last 3-months.

    Read More about Earnings Results

Indices Featuring Sun Pharma Stock

Check stock indices that include Sun Pharma.

BSE Healthcare

₹46,908.38

0.47 (▲217.95%)

Insights on Sun Pharma Advanced Research Company Ltd

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Retail Holding Up

    img

    Retail Investor have increased holdings from 31.41% to 31.76% in May 2026 quarter

  • imgPOSITIVE IMPACT

    FII Holding Up

    img

    Foreign Institutions have increased holdings from 2.04% to 2.47% in May 2026 quarter

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 month, SPARC stock has moved up by 52.1%

  • imgNO EFFECT

    Promoter Holding Unchanged

    img

    Promoters holdings remained unchanged at 65.67% of holdings in May 2026 quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Torrent Pharmaceuticals Ltd has given 144.5% return, outperforming this stock by 131.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Torrent Pharmaceuticals Ltd has given 38.1% return, outperforming this stock by 6.7%

  • imgNEGATIVE IMPACT

    MF Holding Down

    img

    Mutual Funds have decreased holdings from 0.85% to 0.09% in May 2026 quarter

About Sun Pharma Advanced Research Company Ltd

Sun Pharma Advanced Research Company Ltd (“SPARC”) is a clinical stage biopharmaceutical company focused on innovation and new product development for global markets. Established in 2006, it is engaged in the creation of new drugs and delivery systems, undertaking projects in research and technology for new chemical entities (“NCEs”) and novel drug delivery systems (“NDDS”). SPARC operates in global markets including the US, India and China. It has successfully received approvals from the US FDA for various drugs such as ELEPSIA XR Levetiracetam extended-release tablets 1000 mg and 1500 mg, XELPROS Latanoprost BAKfree eyedrops and for XELPROS latanoprost ophthalmic emulsion 0.005 which was inlicensed from Sun Pharma in 2015. In 2021, it commenced the commercialization of ElepsiaTM XR to Visiox Pharma, with eligible milestone payments and royalties and acquired exclusive rights for antibody against a unique oncology target from Biomodifying. SPARC is focused on advancement of clinical trials with vodobatinib being granted orphan drug designation for the treatment of CML and it has completed phase I study of SCD044.

Revenue: ₹13.20Cr as on March 2026 (Q4 FY26)
Net Profit: ₹1,761.34Cr as on March 2026 (Q4 FY26)
Listing date: 18 Jul, 2007
Chairperson Name: Dilip S Shanghvi
OrganisationSun Pharma Advanced Research Company Ltd
HeadquartersMumbai
IndustryPharmaceuticals
CEODilip S Shanghvi
E-voting on sharesClick here to vote

FAQs

What is Sun Pharma share price today?

Sun Pharma share price today stands at ₹212.82 as on at the close of the market. Sun Pharma share today touched a day high of ₹222.59 and a low of ₹210.9.

What is the 52 week high and 52 week low range for Sun Pharma share?

Sun Pharma touched a 52 week high of ₹248.75 and a 52 week low of ₹108. Sun Pharma share price today i.e. is closed at ₹212.82, which is -14.44% down from its 52 week high and 97.06% up from its 52 week low.

What is Sun Pharma's market capitalisation today?

Sun Pharma market capitalisation is ₹6,911.34 Cr as on .

How to buy Sun Pharma shares?

To buy Sun Pharma shares, you need to follow these steps:

  • Open a Demat account and Trading account on INDmoney
  • Fund your Trading account
  • Search for SPARC or Sun Pharma Advanced Research Company Ltd on the INDmoney app to check live prices of the stock
  • Click on Buy or SIP to place an order to invest in Sun Pharma shares. You can invest by selecting the number of shares or set up a fixed SIP to invest every month or week.

What is Sun Pharma trading volume today?

Sun Pharma trading volume is 36.08L as on . This means that 36.08L shares of Sun Pharma were bought and sold on the stock market during today's trading session.